Global PTA Balloon Catheter Market Size

PTA Balloon Catheter Market Analysis

The PTA Balloon Catheter market is expected to register a CAGR of about 7.5% during the forecast period (2022-2027).

The onset of the COVID-19 pandemic has led to a reduction in the number of patient visits that reduced the number of patients opting for surgical procedures, thereby impacting the market growth. As per the study published by the National Library of Medicine in 2021, Compared to periods before initiation of pandemic (BC), the after initiation of pandemic (AC) period was characterized by a marked reduction in the number of activations for ST-elevation myocardial infarction (STEMI), number of activations leading to angiography and number of activations leading to primary percutaneous coronary intervention (PPCI). A decline in STEMI activations drove the reductions in angiography and PPCI volumes. Relative to periods before initiation of the pandemic, the door to balloon (D2B) times after initiation of the pandemic period increased on average by 20%. As a result, the impact of COVID-19 on the market was adverse during the initial phase of the pandemic.

The rising prevalence of cardiovascular disorders and peripheral artery disease, the growing geriatric population, and an increasing number of minimally invasive surgeries are some of the key factors boosting the market growth. Globally there has been an increase in the incidence of cardiac disease, which is negatively impacting people's physical and mental well-being. Thus, the demand for effective and advanced diagnostics and treatment procedures were PTA balloon catheters. Therefore, the market is expected to increase in the forecast period. According to the data published by the European Heart network in 2021 reported that in the European Union more than 60 million people live with Cardiovascular disease and close to 13 million new cases of cardiovascular diseases are diagnosed every year. Hence, due to the high frequency of cardiovascular diseases, interventional heart procedures are increasing around the world. As a result, the PTA balloon catheter market is expected to increase in the coming year.

However, catheters are often associated with vein thrombosis, which may lead to pulmonary embolism and, in some cases, may prove to be fatal. Thrombosis can result in obstruction of a catheter, which includes a fibrin sheath around the intraluminal, venous, and mural thrombosis at the catheter tip. Patients who undergo cardiac catheterization are at a higher risk of catheter-associated bloodstream infections due to repeated use of catheters. Therefore, risks and complications associated with catheters may impede the growth of the market for PTA Balloon Catheters in the coming years. However, they can be overcome with technological advancements.